Aggrecanase Activity ELISA
Please register to view price.
North America: 1-888-USMDBIO
International: +41-44 986 2628
Or you can order by using our online form
Have questions or need bulk? No problem, just ask.
The Aggrecanase Activity ELISA Kit measures activity of aggrecanases and is used to screen and characterize aggrecanase inhibitors. This assay consists of two modules, the Aggrecanase Module and the ELISA Module. In the Aggrecanase Module, a recombinant fragment of human aggrecan interglobular domain (aggrecan-IGD) is first digested with aggrecanase. Proteolytic cleavage of the substrate releases an aggrecan peptide with the N-terminal sequence ARGSVIL (ARGSVIL-peptide). The ARGSVIL-peptide is then quantified in the ELISA Module using two monoclonal anti-peptide sequence antibodies.
Overview
Aggrecanases ADAMTS1, ADAMTS4 and ADAMTS5 are members of the ADAMTS-family of proteases (ADAMTS = A disintegrin and metalloprotease with thrombospondin motif). They are synthesized as multidomain proteins consisting of prodomains, protease, disintegrin, thrombospondin and cys-rich domains followed by spacer regions and additional thrombospondin motifs. The prodomains are cleaved-off intracellularly and the enzymes are processed further from their C-terminal ends after secretion.
Aggrecanases cleave specific peptide bonds in aggrecan, the main proteoglycan of articular cartilage. They hydrolyze also other lecticanes as versican and brevican. Convincing evidence indicates that aggrecanases are mainly responsible for excessive aggrecan degradation in osteoarthritic joints.
Data/Specifications
Species: human
Sample Type: cell culture supernates
Sample Size: 100 uL
Standard Curve Range: 0.062 - 4 nM
Sensitivity: 0.025 nM
Assay Length: 3.75 hours
Literature/Support
Product Insert:
Aggrecanase Activity Assay Insert (PDF)
Articles/FAQ:
Measuring aggrecanase activity to identify potential therapeutics for osteoarthritis. (Blog Post)
How It Works
The Aggrecanase Activity Assay measures activity of aggrecanases. It is used to screen and characterize aggrecanase inhibitors. This assay consists of two modules, the Aggrecanase Module and the ELISA Module. A recombinant fragment of human aggrecan interglobular domain (aggrecan-IGD) is first digested with ag- grecanase. Proteolytic cleavage of the substrate releases an aggrecan peptide with the N-terminal sequence ARGSVIL (ARGSVIL-peptide). The ARGSVIL-peptide is then quantified with two monoclonal anti-peptide antibodies.
Aggrecanase module: Proteolysis of aggrecan-IGD by aggrecanase
Aggrecan-IGD is incubated with standard aggrecanase and samples of unknown aggrecanase activity. In addition to aggrecanase, different concentrations of aggrecanase inhibitors can be added. The reaction is then stopped by dilution with EDTA-containing buffer.
ELISA module: Aggrecan peptide ELISA
ARGSVIL-peptide standard, proteolytic digestions of aggrecan-IGD with standard aggrecanase and samples are incubated in microtiter wells precoated with anti-ARGSVIL-neoepitope antibody. ARGSVIL-peptide is bound to the coated antibody, while other components are removed by washing and aspiration. The bound ARGSVIL-peptide is detected with a second peroxidase-labeled antibody. Any excess of the conjugate is removed by washing and aspiration. The amounts of peroxidase bound to different wells are determined in reactions with peroxidase substrate TMB. The reactions are stopped by addition of sulfuric acid solution and absorbance is read at 450 nm in a microtiter plate spectrophotometer.